Esperion Therapeutics
- Biotech or pharma, therapeutic R&D
Esperion is a pharmaceutical company with the only oral non-statins FDA approved to lower LDL-C and reduce the risk of MI and coronary revascularization in primary prevention and secondary prevention. Strong developing pipeline in renal, liver & oncology. recent development in PSC Primary Sclerosing Cholangitis.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}